Rhea-AI Impact
Rhea-AI Sentiment
Rhea-AI Summary
Good Natured Products Inc. (TSXV: GDNP, OTCQB: GDNPF) announced the closing of its non-brokered private placement offering, generating gross proceeds of $938,399.88 through the issuance of 15,639,998 units at $0.06 per unit. Each unit includes one common share and one warrant, allowing the purchase of an additional share at $0.08 within thirty months. Insiders subscribed for 5,170,000 units, contributing $310,200. The funds will support working capital and cost reduction activities. Additionally, 2,553,125 restricted share units (RSUs) were granted to Board Members as part of their 2024 compensation. Newly elected board member Mark Munford received options for 112,500 common shares and 337,500 RSUs. All securities are subject to a statutory four-month hold period.
Positive
- Raised gross proceeds of $938,399.88 from private placement.
- Funds will be used for working capital and cost reduction activities.
- Insider participation indicates confidence, contributing $310,200.
Negative
- Potential dilution from issuance of 15,639,998 new units.
- Additional dilution from 144,534 compensation warrants and insider subscriptions.
- Warrants and RSUs could lead to further dilution if exercised.
Vancouver, British Columbia–(Newsfile Corp. – June 21, 2024) – good natured Products Inc. (TSXV: GDNP) (OTCQB: GDNPF) (the “Company” or “good natured®“), a North American leader in eco-friendly food packaging, bio-based plastic extrusion and plant-based products, today announces that further to its new releases dated February 14, 2024 and March 22, 2024, the Company has closed its previously announced non-brokered private placement offering (the “Offering”). The Company issued a total of 15,639,998 units (each a “Unit”) at $0.06 per Unit for gross proceeds of $938,399.88 under the Offering.
Each Unit consisted of one common share in the capital of the Company (a “Unit Share”) and one common share purchase warrant (a “Warrant”) of the Company. Each Warrant entitles the holder thereof to acquire one common share (a “Warrant Share”) at an exercise price per Warrant Share of $0.08 (the “Warrant Exercise Price”) for a period of thirty months from the closing of the First Tranche.
In connection with the closing of the Offering, the Company paid aggregate finder’s fees of $8,671.99 and issued an aggregate of 144,534 compensation warrants (each, a “Compensation Warrant”), pursuant to a finder’s fee agreement entered between the Company and a finder. Each Compensation Warrant entitles the holder thereof to purchase one Warrant Share at a price of $0.06 per Warrant Share for a period of thirty months from the date of issuance.
The net proceeds of the Offering are expected to be used by the Company to fund working capital and one-time expenses associated with previously announced cost reduction activities (see press release dated February 14, 2024 and February 1, 2024).
All securities issued pursuant to the above referenced Offering will be subject to a statutory four-month hold period. The Offering is subject to a number of conditions, including without limitation, approval of the TSX Venture Exchange.
Insiders of the Company subscribed for a total of 5,170,000 Units for total gross proceeds of $310,200.00 under the Offering. Participation by insiders constitutes a “related party transaction” as defined under Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”). The Company is relying on exemptions from the formal valuation and minority shareholder approval requirements provided under sections 5.5(a) and 5.7(1)(a) of MI 61-101, as neither the fair market value of the Offered Shares issued to such related parties, nor the consideration paid by such related parties exceeded 25% of the Company’s market capitalization. The Company did not file a material change report in respect of the related party transaction 21 days prior to the closing of the Offering as the details of the participation of insiders of the Company had not been confirmed at that time. Further details will be provided in a material change report to be filed by the Company subsequent to the dissemination of this press release.
The Units have not been, nor will they be, registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold in the United States or to, for the account or benefit of, “U.S. persons” (as such term is defined in Regulation S under the U.S. Securities Act) absent registration under the U.S. Securities Act or and applicable state securities laws or pursuant to an applicable exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws.
This news release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.
Grant of Equity Shares in lieu of Cash Compensation for Board members
Pursuant to the Company’s Omnibus Equity Incentive Compensation Plan, an aggregate 2,553,125 restricted share units (“RSUs”) were granted across the five Board Members of the Company in lieu of the typical cash component of their compensation for the 2024 calendar year. The RSUs will vest in a single tranche at the conclusion of the 2024 calendar year.
Granting of new Board Member 2024 Equity Component
Pursuant to the Company’s Omnibus Equity Incentive Compensation Plan, the Board approved the granting of share compensation for 2024 to the newly elected board member, Mark Munford. Options to purchase 112,500 common shares were granted, with an exercise price of $0.07 per common share. The stock options have a term of five years and vest over a 48-month period. The Company also granted Mr. Munford an aggregate of 337,500 RSUs, vesting in equal portions over a three-year term.
Each RSU entitles the holder thereof to receive either one common share, the cash equivalent of one common share or a combination of cash and common shares, as determined by the Company.
The granting of these options and RSUs is subject to TSX Venture Exchange approval.
The good natured® corporate profile can be found at: goodnaturedproducts.com/pages/investor
About good natured Products Inc.
good natured® is at the forefront of North America’s shift toward sustainability, showcasing over 90 plant-based packaging designs and an extensive portfolio of more than 400 products and services. These offerings are purposefully designed to reduce environmental impact by using more renewable materials, less fossil fuel, and eliminating chemicals of concern.
Manufactured locally in the US and Canada, good natured® engineers and distributes a diverse range of bio-based products across various sectors, including grocery, restaurant, electronics, automotive, and pharmaceutical via both wholesale and direct channels.
The Company is dedicated to providing an industry-leading customer experience in order to encourage the transition to renewable alternatives. By making it easy and affordable for businesses to adopt bio-based products and packaging, good natured® aims to empower them to reach their sustainability objectives.
For more information: goodnaturedproducts.com
On behalf of the Company:
Paul Antoniadis – Executive Chair & CEO
Contact: 1-604-566-8466
Investor Contact:
Spencer Churchill
Investor Relations
1-877-286-0617 ext. 113
invest@goodnaturedproducts.com
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibilities for the adequacy or accuracy of this release.
Cautionary Statement Regarding Forward-Looking Information
This press release contains “forward-looking statements” within the meaning of applicable securities laws. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “budget,” “believe,” “project,” “estimate,” “expect,” “scheduled,” “forecast,” “strategy,” “future,” “likely,” “may,” “to be,” “could,”, “would,” “should,” “will” and similar references to future periods or the negative or comparable terminology, as well as terms usually used in the future and the conditional.
By their nature, forward-looking statements involve known and unknown risks, uncertainties, changes in circumstances and other factors that are difficult to predict and many of which are outside of the Company’s control which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.
Forward-looking information contained in this news release is based on our current estimates, expectations and projections regarding, among other things, future plans and strategies, the intention to complete the Offering and the expected expenditure of the proceeds of the Offering, the granting of security-based compensation and the terms thereof, projections, future market and operating conditions, supply conditions, end customer demand conditions, anticipated events and trends, general market conditions, the economy, financial conditions, sales volume and pricing, expenses and costs, and other future conditions which we believe are reasonable as of the current date. Important factors that could cause actual results and financial conditions to differ materially from those indicated in the forward-looking statements include, but are not limited to: future capital needs and uncertainty of additional financing, risks relating to general economic, market and business conditions and unforeseen delays in the realization of the Company’s plans, risks related to the loss of key manufacturing equipment, capability or facilities, the performance of plant-based materials and the ability of the Company’s products and packaging to meet significant technical requirements, changes in raw material supply and costs, labour availability and labour costs, fluctuations in operating results, and other related risks as more fully set out in the Annual Information Form of the Company and other documents disclosed under the Company’s filings at www.sedar.com. The reader should not place undue importance on forward-looking information and should not rely upon this information as of any other date. Important factors that could cause actual results and financial conditions to differ materially from those indicated in the forward-looking statements include, among others:
The Company considers its assumptions to be reasonable based on currently available information, but cautions the reader that its assumptions regarding future events, many of which are beyond the control of the Company, may ultimately prove to be incorrect since they are subject to risks and uncertainties that affect the Company and its businesses. When relying on the Company’s forward-looking statements and information to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. The Company has assumed that the material factors referred to above will not cause such forward-looking statements and information to differ materially from actual results or events. However, there can be no assurance that such assumptions will reflect the actual outcome of such items or factors.
Other than as required under securities laws, the Company does not undertake to update this information at any particular time.
Forward-looking statements contained in this news release are based on the Company’s current estimates, expectations and projections regarding, among other things, sales volume and pricing which it believes are reasonable as of the current date. The reader should not place undue importance on forward-looking statements and should not rely upon these statements as of any other date. All forward-looking statements contained in this news release are expressly qualified in their entirety by this cautionary statement.
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/213908
FAQ
What was the total amount raised in the private placement by Good Natured Products?
Good Natured Products raised a total of $938,399.88 through their non-brokered private placement.
How many units were issued in Good Natured Products’ private placement?
Good Natured Products issued 15,639,998 units in their private placement.
What is the exercise price of the warrants issued by Good Natured Products?
The exercise price of the warrants issued is $0.08 per share.
How much did insiders invest in the private placement of Good Natured Products?
Insiders invested $310,200 in the private placement, subscribing for 5,170,000 units.
What will the proceeds from Good Natured Products’ private placement be used for?
The proceeds will be used to fund working capital and cost reduction activities.
What is the hold period for the securities issued in Good Natured Products’ private placement?
The securities issued are subject to a statutory four-month hold period.
What compensation did Board Members of Good Natured Products receive for 2024?
Board Members were granted 2,553,125 restricted share units (RSUs) as part of their 2024 compensation.
What equity incentives were granted to the newly elected board member Mark Munford of Good Natured Products?
Mark Munford received options for 112,500 common shares and 337,500 restricted share units (RSUs).
